Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
99,005,686
-
Shares change
-
+6,223,912
-
Total reported value, excl. options
-
$3,277,197,416
-
Value change
-
+$103,173,273
-
Put/Call ratio
-
131%
-
Number of buys
-
132
-
Number of sells
-
-132
-
Price
-
$33.10
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q4 2016
313 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share as of Q4 2016.
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99,005,686 shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (11,960,724 shares), WELLINGTON MANAGEMENT GROUP LLP (10,168,929 shares), WELLS FARGO & COMPANY/MN (9,104,401 shares), JPMORGAN CHASE & CO (7,646,240 shares), VANGUARD GROUP INC (5,311,683 shares), BAIN CAPITAL INVESTORS LLC (3,452,202 shares), Pennant Capital Management, LLC (3,210,062 shares), GOLDMAN SACHS GROUP INC (2,384,722 shares), TCW GROUP INC (2,251,809 shares), and BlackRock Institutional Trust Company, N.A. (1,999,875 shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.